What is it about?
Conjunctiva from the same eye of the patient is used to cover the raw surface in one group of patients and mitomycin-C is used in another group of patients on the raw surface left after pterygium removal. When compared to conjunctival autografting that was safe with low regrowth rate, there were some drug induced complications apart from its recurrence prevention ability
Featured Image
Why is it important?
Autologous conjunctival transplantation showed promising results in both safety and recurrence prevention than mitomycin-C.
Perspectives
We greet fully thank editorial board committee and reviewers of this journal publication for their cooperation who were also responsible for manuscript improvement and conveying lucid message.
Professor Head ophthalmology prabhakar srinivasapuram krishnacharya
JSS academy of higher education and research
Read the Original
This page is a summary of: Comparative study of the results of 0.04% Mitomycin-C and simple conjunctival auto-graft for primary pterygium, Apollo Medicine, September 2013, Elsevier,
DOI: 10.1016/j.apme.2013.08.001.
You can read the full text:
Resources
Contributors
The following have contributed to this page
